Application of small compounds in the epigenetic therapy of malignant brain gliomas

2020/37/B/NZ5/03249

Keywords

Descriptors

  • NZ5_007: Leczenie chorób człowieka
  • NZ5_003: Patogeneza chorób człowieka

Panel

NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)

Host institution

Instytut Chemii Bioorganicznej PAN

Voivodeship: wielkopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Mirosława Zofia Naskręt-Barciszewska

Number of co-investigators in the project: 5

Call

OPUS 19 – announced on 2020-03-16

Amount awarded
973 200 PLN
Project start date
2021-02-01
Project end date
2025-12-31
Project duration
59 months (the same as in the proposal)
Project status
Project completed

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (3)

  1. Mechanistic Insights on Metformin and Arginine Implementation as Repurposed Drugs in Glioblastoma Treatment

    Authors:
    Anna-Maria Barciszewska, Agnieszka Belter, Jakub F. Barciszewski, Iwona Gawrońska, Małgorzata Giel-Pietraszuk, Mirosława Z. Naskręt-Barciszewska
    Academic press:
    International Journal of Molecular Sciences (year: 2024, volume: 25, pages: 9460), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms25179460 – link to the publication
  2. Cross-reactivity between histone demethylase inhibitor valproic acid and DNA methylation in glioblastoma cell lines

    Authors:
    Anna-Maria Barciszewska, Agnieszka Belter, Iwona Gawrońska, Małgorzata Giel-Pietraszuk, Mirosława Z. Naskręt-Barciszewska
    Academic press:
    Frontiers in Oncology (year: 2022, volume: 12, pages: 1033035), Publisher: Frontiers
    Status:
    Published
    DOI:
    10.3389/fonc.2022.1033035 – link to the publication
  3. Juglone in Combination with Temozolomide Shows a Promising Epigenetic Therapeutic Effect on the Glioblastoma Cell Line

    Authors:
    Anna-Maria Barciszewska, Agnieszka Belter, Iwona Gawrońska, Małgorzata Giel-Pietraszuk, Mirosława Z. Naskręt-Barciszewska
    Academic press:
    International Journal of Molecular Sciences (year: 2023, volume: 24(8), pages: 6998), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms24086998 – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski